Literature DB >> 18325342

Human fortilin is a molecular target of dihydroartemisinin.

Takayuki Fujita1, Kumar Felix, Decha Pinkaew, Nongporn Hutadilok-Towatana, Zhihe Liu, Ken Fujise.   

Abstract

Dehydroartemisinin (DHA) is an effective anti-malaria agent. Fortilin is an anti-apoptotic molecule overexpressed in many human cancers. Here, we show that DHA binds human fortilin, increases the ubiquitination of fortilin, shortens fortilin's half-life in a proteasome-dependent fashion, and reduces cellular levels of fortilin in varieties of cells. DHA induced DNA fragmentation in U2OS cells in a fortilin-dependent manner. The fortilin-knocked-down cells were less susceptible--and fortilin-overexpressing cells more susceptible--to DHA than were wild-type cells, suggesting that apoptotic effects of DHA are-at least partly-conferred through fortilin. Together, these data suggest that fortilin is a molecular target of DHA. DHA and its derivative may prove to be viable anti-cancer agents in fortilin-overexpressing cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325342      PMCID: PMC2727609          DOI: 10.1016/j.febslet.2008.02.055

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.

Authors:  A Frostell-Karlsson; A Remaeus; H Roos; K Andersson; P Borg; M Hämäläinen; R Karlsson
Journal:  J Med Chem       Date:  2000-05-18       Impact factor: 7.446

2.  Studies of small molecule interactions with protein phosphatases using biosensor technology.

Authors:  Peter Stenlund; Asa Frostell-Karlsson; Olof P Karlsson
Journal:  Anal Biochem       Date:  2006-03-20       Impact factor: 3.365

3.  Characterization of fortilin, a novel antiapoptotic protein.

Authors:  F Li; D Zhang; K Fujise
Journal:  J Biol Chem       Date:  2001-10-11       Impact factor: 5.157

4.  Immunoprecipitation of [(3)H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies.

Authors:  J Bhisutthibhan; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

5.  Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone.

Authors:  Di Zhang; Franklin Li; Douglas Weidner; Zakar H Mnjoyan; Ken Fujise
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

6.  Molecular cloning and expression of a mammalian homologue of a translationally controlled tumor protein (TCTP) gene from Penaeus monodon shrimp.

Authors:  Phuwadol Bangrak; Potchanapond Graidist; Wilaiwan Chotigeat; Amornrat Phongdara
Journal:  J Biotechnol       Date:  2004-03-18       Impact factor: 3.307

7.  Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity.

Authors:  Potchanapond Graidist; Amornrat Phongdara; Ken Fujise
Journal:  J Biol Chem       Date:  2004-07-15       Impact factor: 5.157

Review 8.  Chemical studies on qinghaosu (artemisinine). China Cooperative Research Group on qinghaosu and its derivatives as antimalarials.

Authors: 
Journal:  J Tradit Chin Med       Date:  1982-03       Impact factor: 0.848

9.  Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1.

Authors:  Marcel Tuynder; Laurent Susini; Sylvie Prieur; Stephanie Besse; Giusy Fiucci; Robert Amson; Adam Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-24       Impact factor: 11.205

Review 10.  Qinghaosu (artemisinin): an antimalarial drug from China.

Authors:  D L Klayman
Journal:  Science       Date:  1985-05-31       Impact factor: 47.728

View more
  17 in total

Review 1.  Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

Authors:  Decha Pinkaew; Ken Fujise
Journal:  Adv Clin Chem       Date:  2017-08-07       Impact factor: 5.394

2.  Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies.

Authors:  Maranda S Cantrell; Jackson D Wall; Xinzhu Pu; Matthew Turner; Luke Woodbury; Ken Fujise; Owen M McDougal; Lisa R Warner
Journal:  Protein Expr Purif       Date:  2021-10-06       Impact factor: 1.650

Review 3.  Translationally controlled tumor protein: the mediator promoting cancer invasion and migration and its potential clinical prospects.

Authors:  Junying Gao; Yan Ma; Guiwen Yang; Guorong Li
Journal:  J Zhejiang Univ Sci B       Date:  2022-08-15       Impact factor: 5.552

4.  Fortilin reduces apoptosis in macrophages and promotes atherosclerosis.

Authors:  Decha Pinkaew; Rachel J Le; Yanjie Chen; Mahmoud Eltorky; Ba-Bie Teng; Ken Fujise
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

5.  Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-kappaB.

Authors:  Hua Chen; Bei Sun; Shuangjia Wang; Shangha Pan; Yue Gao; Xuewei Bai; Dongbo Xue
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-26       Impact factor: 4.553

6.  Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells.

Authors:  Sho Hangai; Takeshi Kawamura; Yoshitaka Kimura; Ching-Yun Chang; Sana Hibino; Daisuke Yamamoto; Yousuke Nakai; Ryosuke Tateishi; Masanobu Oshima; Hiroko Oshima; Tatsuhiko Kodama; Kyoji Moriya; Kazuhiko Koike; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Nat Immunol       Date:  2021-07-08       Impact factor: 25.606

7.  Fortilin potentiates the peroxidase activity of Peroxiredoxin-1 and protects against alcohol-induced liver damage in mice.

Authors:  Abhijnan Chattopadhyay; Decha Pinkaew; Hung Q Doan; Reed B Jacob; Sunil K Verma; Hana Friedman; Alan C Peterson; Muge N Kuyumcu-Martinez; Owen M McDougal; Ken Fujise
Journal:  Sci Rep       Date:  2016-01-04       Impact factor: 4.379

8.  Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells.

Authors:  Maria Lucibello; Sara Adanti; Ester Antelmi; Dario Dezi; Stefania Ciafrè; Maria Luisa Carcangiu; Manuela Zonfrillo; Giuseppe Nicotera; Lorenzo Sica; Filippo De Braud; Pasquale Pierimarchi
Journal:  Oncotarget       Date:  2015-03-10

9.  Elevation of serum fortilin levels is specific for apoptosis and signifies cell death in vivo.

Authors:  Patuma Sinthujaroen; Nattaporn Wanachottrakul; Decha Pinkaew; John R Petersen; Amornrat Phongdara; Melinda Sheffield-Moore; Ken Fujise
Journal:  BBA Clin       Date:  2014-12-01

Review 10.  Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Authors:  Luiza Helena Gremski; Fernando Hitomi Matsubara; Nayanne Louise Costacurta Polli; Bruno Cesar Antunes; Pedro Henrique de Caires Schluga; Hanna Câmara da Justa; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Front Mol Biosci       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.